NCT06043609Recruiting
Outcome Evaluation After Fertility Preservation
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
It is important to evaluate outcomes after different fertility preservation strategies. Therefore, this study aims to assess the outcomes after different fertility preservation strategies and identify any factors that may affect their reproductive outcome.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 12 Sept 2023
- Start date
- 21 Sept 2023
- Primary completion date
- 1 Oct 2033
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Childhood cancers
- NCT number
- NCT06043609
What you commit to
- Study type: Observational
- Planned participants: 100
- From 21 Sept 2023 to the primary completion date, 1 Oct 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)
Who the study is looking for
- Patients aged from 0-50 years old
- Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
- Patients seek for fertility preservation services
Age in the registry: - to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.